Nomura Holdings’s Edwards Lifesciences EW Stock Holding History

Nomura Holdings’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-100,000	Closed	-$8.53M	–	1827
2025 Q4	$8.53M	Sell	100,000 -50,000	-33%	-$4.1M	0.01%	590
2025 Q3	$11.7M	Buy	+150,000	New	+$11.7M	0.02%	479
2025 Q2	–	Sell	-37,900	Closed	-$2.75M	–	1617
2025 Q1	$2.75M	Sell	37,900 -55,300	-59%	-$3.96M	0.01%	932
2024 Q4	$6.9M	Buy	+93,200	New	+$6.52M	0.01%	652
2022 Q4	–	Sell	-17,000	Closed	-$1.41M	–	1560
2022 Q3	$1.41M	Buy	+17,000	New	+$1.64M	0.01%	874

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nomura Holdings's EW Position: Q1 2026 in Review

Nomura Holdings reduced its Edwards Lifesciences (EW) stake by 96% in Q1 2026, selling an estimated $6.15M and leaving 3,082 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1531.

Nomura Holdings first reported a position in EW in Q2 2013 and has held it in 35 quarters since. The position peaked at $29.2M in Q1 2024. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Nomura Holdings held 3,082 shares of Edwards Lifesciences worth $247K as of Q1 2026.
Nomura Holdings sold 74,556 Edwards Lifesciences shares in Q1 2026, an estimated $6.15M.
Edwards Lifesciences made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1531 holding.
Nomura Holdings first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 35 quarters since.
Nomura Holdings's Edwards Lifesciences position peaked at $29.2M in Q1 2024.
1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.